Vir Biotechnology, Inc. Increase (Decrease) in Deferred Income Taxes
Vir Biotechnology, Inc. (VIR) reported Increase (Decrease) in Deferred Income Taxes of $1.06 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2024-02-26
- Vir Biotechnology, Inc. increase (decrease) in deferred income taxes for fiscal 2023 was $1.06M, a 93.00% decline from fiscal 2022.
- Vir Biotechnology, Inc. increase (decrease) in deferred income taxes for fiscal 2022 was $15.19M.
- Vir Biotechnology, Inc. increase (decrease) in deferred income taxes for fiscal 2021 was -$15.19M, a 29303.85% decline from fiscal 2020.
- Vir Biotechnology, Inc. increase (decrease) in deferred income taxes for fiscal 2020 was $52.00K.
| Period end | Increase (Decrease) in Deferred Income Taxes 12 month |
|---|---|
| 2023-12-31 | $1.06M 10-K · filed 2024-02-26 |
| 2022-12-31 | $15.19M 10-K · filed 2024-02-26 |
| 2021-12-31 | -$15.19M 10-K · filed 2024-02-26 |
| 2020-12-31 | $52.00K 10-K · filed 2023-02-28 |
| 2018-12-31 | $480.00K 10-K · filed 2021-02-25 |
| 2017-12-31 | $10.92M 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |